Articles

Combining ibrutinib and checkpoint blockade improves CD8+ T-cell function and control of chronic lymphocytic leukemia in Em-TCL1 mice

Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany;
Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany;
Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany;
Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany;
Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany;
Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany;
Internal Medicine III, University of Ulm, Ulm, Germany
Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany;
Haematologica Early view Mar 5, 2020 https://doi.org/10.3324/haematol.2019.238154